C/EBPα negatively regulates SIRT7 expression via recruiting HDAC3 to the upstream-promoter of hepatocellular carcinoma cells

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1859, Issue 2, 2016, Pages 348-354

  Liu, Gui Fen ^a   Lu, Jian Yi ^a   Zhang, Yan Jun ^a   Zhang, Lang Xi ^a   Lu, Guo Dong ^b   Xie, Ze Jun ^b   Cheng, Mo Bin ^a   Shen, Yu Fei ^a   Zhang, Ye ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

C EBP; HDAC3; SIRT7; Transcription

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; CCAAT ENHANCER BINDING PROTEIN DELTA; HISTONE DEACETYLASE 3; SIRTUIN 7; 3' UNTRANSLATED REGION; CCAAT ENHANCER BINDING PROTEIN; CEBPA PROTEIN, HUMAN; CHROMATIN; HISTONE DEACETYLASE; SIRT7 PROTEIN, HUMAN; SIRTUIN;

ARTICLE; CARCINOMA CELL; CHROMATIN IMMUNOPRECIPITATION; CODON; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; ENZYME ACTIVE SITE; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; 3' UNTRANSLATED REGION; ANIMAL; BIOSYNTHESIS; CHROMATIN; GENETICS; LIVER TUMOR; PATHOLOGY; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; ANIMALS; CARCINOMA, HEPATOCELLULAR; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CCAAT-ENHANCER-BINDING PROTEINS; CELL LINE, TUMOR; CHROMATIN; HISTONE DEACETYLASES; HUMANS; LIVER NEOPLASMS; PROMOTER REGIONS, GENETIC; SIRTUINS;

EID: 84951326022     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2015.12.004     Document Type: Article

References (40)

1. Giblin W., Skinner M.E., Lombard D.B. Sirtuins: guardians of mammalian healthspan. Trends in genetics: TIG 2014, 30:271-286.
2. Rogina B., Helfand S.L. Sir2 Mediates Longevity in the Fly Through a Pathway Related to Calorie Restriction. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:15998-16003.
3. Tissenbaum H.A., Guarente L. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 2001, 410:227-230.
4. Martinez-Redondo P., Vaquero A. The diversity of histone versus nonhistone sirtuin substrates. Genes & cancer 2013, 4:148-163.
5. Houtkooper R.H., Pirinen E., Auwerx J. Sirtuins as regulators of metabolism and healthspan. Nat. Rev. Mol. Cell Biol. 2012, 13:225-238.
6. Michishita E., Park J.Y., Burneskis J.M., Barrett J.C., Horikawa I. Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol. Biol. Cell 2005, 16:4623-4635.
7. Blander G., Guarente L. The Sir2 family of protein deacetylases. Annu. Rev. Biochem. 2004, 73:417-435.
8. Ford E., Voit R., Liszt G., Magin C., Grummt I., Guarente L. Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription. Genes Dev. 2006, 20:1075-1080.
9. Kiran S., Chatterjee N., Singh S., Kaul S.C., Wadhwa R., Ramakrishna G. Intracellular distribution of human SIRT7 and mapping of the nuclear/nucleolar localization signal. The FEBS Journal 2013, 280:3451-3466.
10. Percipalle P., Fomproix N., Cavellan E., Voit R., Reimer G., Kruger T., Thyberg J., Scheer U., Grummt I., Farrants A.K. The chromatin remodelling complex WSTF-SNF2h interacts with nuclear myosin 1 and has a role in RNA polymerase I transcription. EMBO Rep. 2006, 7:525-530.
11. Cavellan E., Asp P., Percipalle P., Farrants A.K. The WSTF-SNF2h chromatin remodeling complex interacts with several nuclear proteins in transcription. J. Biol. Chem. 2006, 281:16264-16271.
12. Barber M.F., Michishita-Kioi E., Xi Y., Tasselli L., Kioi M., Moqtaderi Z., Tennen R.I., Paredes S., Young N.L., Chen K., Struhl K., Garcia B.A., Gozani O., Li W., Chua K.F. SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation. Nature 2012, 487:114-118.
13. Tsai Y.C., Greco T.M., Boonmee A., Miteva Y., Cristea I.M. Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription. Molecular & Cellular Proteomics: MCP 2012, 11:60-76.
14. Vakhrusheva O., Smolka C., Gajawada P., Kostin S., Boettger T., Kubin T., Braun T., Bober E. Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice. Circ. Res. 2008, 102:703-710.
15. Ryu D., Jo Y.S., Lo Sasso G., Stein S., Zhang H., Perino A., Lee J.U., Zeviani M., Romand R., Hottiger M.O., Schoonjans K., Auwerx J. A SIRT7-dependent acetylation switch of GABPbeta1 controls mitochondrial function. Cell Metab. 2014, 20:856-869.
16. Yoshizawa T., Karim M.F., Sato Y., Senokuchi T., Miyata K., Fukuda T., Go C., Tasaki M., Uchimura K., Kadomatsu T., Tian Z., Smolka C., Sawa T., Takeya M., Tomizawa K., Ando Y., Araki E., Akaike T., Braun T., Oike Y., Bober E., Yamagata K. SIRT7 controls hepatic lipid metabolism by regulating the ubiquitin-proteasome pathway. Cell Metab. 2014, 19:712-721.
17. Mohrin M., Shin J., Liu Y., Brown K., Luo H., Xi Y., Haynes C.M., Chen D. Stem cell aging. A mitochondrial UPR-mediated metabolic checkpoint regulates hematopoietic stem cell aging. Science 2015, 347:1374-1377.
18. Han Y., Liu Y., Zhang H., Wang T., Diao R., Jiang Z., Gui Y., Cai Z. Hsa-miR-125b suppresses bladder cancer development by down-regulating oncogene SIRT7 and oncogenic long non-coding RNA MALAT1. FEBS Lett. 2013, 587:3875-3882.
19. Kim J.K., Noh J.H., Jung K.H., Eun J.W., Bae H.J., Kim M.G., Chang Y.G., Shen Q., Park W.S., Lee J.Y., Borlak J., Nam S.W. Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b. Hepatology 2013, 57:1055-1067.
20. Lu G.D., Ang Y.H., Zhou J., Tamilarasi J., Yan B., Lim Y.C., Srivastava S., Salto-Tellez M., Hui K.M., Shen H.M., Nguyen L.N., Tan B.C., Silver D.L., Hooi S.C. CCAAT/enhancer binding protein alpha predicts poorer prognosis and prevents energy starvation-induced cell death in hepatocellular carcinoma. Hepatology 2015, 61:965-978.
21. Lu G.D., Leung C.H., Yan B., Tan C.M., Low S.Y., Aung M.O., Salto-Tellez M., Lim S.G., Hooi S.C. C/EBPalpha is up-regulated in a subset of hepatocellular carcinomas and plays a role in cell growth and proliferation. Gastroenterology 2010, 139:632-643. 643 e631-634.
22. Zhao J.C., Zhang L.X., Zhang Y., Shen Y.F. The differential regulation of Gap43 gene in the neuronal differentiation of P19 cells. J. Cell. Physiol. 2012, 227:2645-2653.
23. Cheng M.B., Zhang Y., Cao C.Y., Zhang W.L., Zhang Y., Shen Y.F. Specific phosphorylation of histone demethylase KDM3A determines target gene expression in response to heat shock. PLoS Biol. 2014, 12.
24. Zhang Y., Zhang Y.J., Zhao H.Y., Zhai Q.L., Zhang Y., Shen Y.F. The impact of R213 mutation on p53-mediated p21 activity. Biochimie 2014, 99:215-218.
25. Voelter-Mahlknecht S., Letzel S., Mahlknecht U. Fluorescence in situ hybridization and chromosomal organization of the human Sirtuin 7 gene. Int. J. Oncol. 2006, 28:899-908.
26. Osada S., Yamamoto H., Nishihara T., Imagawa M. DNA binding specificity of the CCAAT/enhancer-binding protein transcription factor family. The Journal of Biological Chemistry 1996, 271:3891-3896.
27. Ramji D.P., Foka P. CCAAT/enhancer-binding proteins: structure, function and regulation. The Biochemical Journal 2002, 365:561-575.
28. Kyrylenko S., Kyrylenko O., Suuronen T., Salminen A. Differential regulation of the Sir2 histone deacetylase gene family by inhibitors of class I and II histone deacetylases. Cell. Mol. Life Sci. 2003, 60:1990-1997.
29. Yang W.M., Tsai S.C., Wen Y.D., Fejer G., Seto E. Functional domains of histone deacetylase-3. The Journal of Biological Chemistry 2002, 277:9447-9454.
30. Yang C., Bolotin E., Jiang T., Sladek F.M., Martinez E. Prevalence of the initiator over the TATA box in human and yeast genes and identification of DNA motifs enriched in human TATA-less core promoters. Gene 2007, 389:52-65.
31. Smale S.T., Kadonaga J.T. The RNA polymerase II core promoter. Annu. Rev. Biochem. 2003, 72:449-479.
32. Nerlov C. The C/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control. Trends Cell Biol. 2007, 17:318-324.
33. Lekstrom-Himes J., Xanthopoulos K.G. Biological role of the CCAAT/enhancer-binding protein family of transcription factors. The Journal of Biological Chemistry 1998, 273:28545-28548.
34. Jakobsen J.S., Waage J., Rapin N., Bisgaard H.C., Larsen F.S., Porse B.T. Temporal mapping of CEBPA and CEBPB binding during liver regeneration reveals dynamic occupancy and specific regulatory codes for homeostatic and cell cycle gene batteries. Genome Res. 2013, 23:592-603.
35. Diehl A.M., Yang S.Q. Regenerative changes in C/EBP alpha and C/EBP beta expression modulate binding to the C/EBP site in the c-fos promoter. Hepatology 1994, 19:447-456.
36. Frye R. "SIRT8" expressed in thyroid cancer is actually SIRT7. Br. J. Cancer 2002, 87:1479.
37. Guenther M.G., Barak O., Lazar M.A. The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3. Mol. Cell. Biol. 2001, 21:6091-6101.
38. Wen Y.D., Perissi V., Staszewski L.M., Yang W.M., Krones A., Glass C.K., Rosenfeld M.G., Seto E. The Histone Deacetylase-3 Complex Contains Nuclear Receptor Corepressors. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:7202-7207.
39. Wu L.M., Yang Z., Zhou L., Zhang F., Xie H.Y., Feng X.W., Wu J., Zheng S.S. Identification of histone deacetylase 3 as a biomarker for tumor recurrence following liver transplantation in HBV-associated hepatocellular carcinoma. PLoS One 2010, 5.
40. Xu W.S., Parmigiani R.B., Marks P.A. Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene 2007, 26:5541-5552.